SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 405 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $522,506 | +298.0% | 3,307 | +226.1% | 0.01% | +200.0% |
Q1 2024 | $131,272 | +84.2% | 1,014 | +37.2% | 0.00% | +200.0% |
Q4 2023 | $71,262 | -88.8% | 739 | -85.9% | 0.00% | -95.0% |
Q3 2023 | $635,072 | +90.4% | 5,239 | +79.8% | 0.02% | +81.8% |
Q2 2023 | $333,597 | +52270.0% | 2,913 | -37.0% | 0.01% | -45.0% |
Q1 2023 | $637 | +69.4% | 4,623 | +59.5% | 0.02% | +25.0% |
Q4 2022 | $376 | -99.4% | 2,899 | +397.3% | 0.02% | +1500.0% |
Q3 2022 | $65,000 | -94.6% | 583 | -96.4% | 0.00% | -96.3% |
Q2 2022 | $1,199,000 | +23.2% | 15,986 | +28.4% | 0.03% | +200.0% |
Q1 2022 | $973,000 | +70.4% | 12,455 | +96.5% | 0.01% | -10.0% |
Q4 2021 | $571,000 | +202.1% | 6,339 | +210.4% | 0.01% | +100.0% |
Q3 2021 | $189,000 | -50.9% | 2,042 | -58.8% | 0.01% | -50.0% |
Q2 2021 | $385,000 | +442.3% | 4,951 | +419.5% | 0.01% | +900.0% |
Q1 2021 | $71,000 | -89.8% | 953 | -76.6% | 0.00% | -95.2% |
Q4 2020 | $694,000 | -4.4% | 4,070 | -21.3% | 0.02% | +162.5% |
Q3 2020 | $726,000 | +1016.9% | 5,169 | +1176.3% | 0.01% | +166.7% |
Q2 2020 | $65,000 | -48.0% | 405 | -58.2% | 0.00% | -70.0% |
Q4 2019 | $125,000 | +166.0% | 970 | +55.2% | 0.01% | +233.3% |
Q3 2019 | $47,000 | +4600.0% | 625 | +8828.6% | 0.00% | – |
Q1 2019 | $1,000 | -96.2% | 7 | -97.0% | 0.00% | -100.0% |
Q4 2018 | $26,000 | -29.7% | 237 | +3.0% | 0.00% | -33.3% |
Q3 2018 | $37,000 | +1133.3% | 230 | +277.0% | 0.00% | – |
Q4 2017 | $3,000 | +50.0% | 61 | +38.6% | 0.00% | – |
Q3 2017 | $2,000 | -98.5% | 44 | -99.1% | 0.00% | -100.0% |
Q4 2016 | $132,000 | +76.0% | 4,811 | +293.1% | 0.01% | +100.0% |
Q3 2016 | $75,000 | +257.1% | 1,224 | +9.6% | 0.01% | +250.0% |
Q2 2016 | $21,000 | – | 1,117 | – | 0.00% | – |
Q1 2016 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Q4 2015 | $14,000 | -82.7% | 353 | -85.9% | 0.00% | -75.0% |
Q3 2015 | $81,000 | +326.3% | 2,498 | +298.4% | 0.01% | +300.0% |
Q2 2015 | $19,000 | -82.2% | 627 | -92.2% | 0.00% | -84.6% |
Q1 2015 | $107,000 | +1428.6% | 8,045 | +1633.8% | 0.01% | +1200.0% |
Q4 2014 | $7,000 | +250.0% | 464 | +293.2% | 0.00% | – |
Q4 2013 | $2,000 | -97.0% | 118 | -91.5% | 0.00% | -100.0% |
Q3 2013 | $66,000 | -25.8% | 1,390 | -40.6% | 0.01% | 0.0% |
Q2 2013 | $89,000 | – | 2,341 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Asymmetry Capital Management, L.P. | 87,180 | $2,581,000 | 3.60% |
Perceptive Advisors | 1,771,029 | $52,422,000 | 2.99% |
SPHERA FUNDS MANAGEMENT LTD. | 483,047 | $14,298,000 | 2.80% |
HealthCor Management, L.P. | 1,550,000 | $45,880,000 | 2.10% |
Camber Capital Management LP | 1,350,000 | $39,960,000 | 1.62% |
Tourbillon Capital Partners, L.P. | 1,537,518 | $45,511,000 | 1.17% |
Elk Creek Partners, LLC | 562,522 | $16,651,000 | 1.02% |
EMERALD ADVISERS, LLC | 818,705 | $24,234,000 | 1.00% |
EMERALD MUTUAL FUND ADVISERS TRUST | 604,467 | $17,892,000 | 0.82% |
Carlson Capital, L.P. | 1,845,702 | $54,633,000 | 0.70% |